ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lammers, J.
Right arrow Articles by Chung, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lammers, J.
Right arrow Articles by Chung, K.
Eur Respir J 1992; 5: 239-246
Copyright © ERS Journals Ltd 1992


Original Articles

Nonadrenergic, noncholinergic airway inhibitory nerves

JW Lammers, PJ Barnes, and KF Chung

Nonadrenergic, noncholinergic (NANC) nerves, which cause relaxation of airway smooth muscle, have been described in several species including man. Stimulation of efferent vagus nerves during cholinergic and adrenergic blockade induces a pronounced bronchodilation in the cat. In more recent studies in man, capsaicin inhalation or mechanical irritation of the larynx, under conditions of cholinergic and adrenergic blockade, have been shown to cause a transient bronchodilator response. There is some evidence that neuropeptides such as vasointestinal peptide (VIP) or peptide histidine methionine (PHM) may be the neurotransmitter of NANC nerves, but this is not conclusive. Nitric oxide may be another neurotransmitter. In mild asthma, the NANC bronchodilator response is similar to that observed in normal subjects; on the other hand, a reduction in VIP immunoreactivity has been reported in more severe patients. The contribution of NANC dilator nerves in pathophysiological situations is not known, but their effect may be modulated during allergic responses. Use of antagonists or inhibitors of putative neurotransmitters, and molecular biological techniques will be useful in defining both the physiological and pathophysiological roles of NANC inhibitory nerves in the airways.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Kreier and R. M. Buijs
Evidence for parasympathetic innervation of white adipose tissue, clearing up some vagaries
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R548 - R549.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. CHANEZ, D. SPRINGALL, A. M. VIGNOLA, A. MORADOGHI-HATTVANI, J. M. POLAK, P. GODARD, and J. BOUSQUET
Bronchial Mucosal Immunoreactivity of Sensory Neuropeptides in Severe Airway Diseases
Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 985 - 990.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. KURIYAMA, K. KITAMURA, T. ITOH, and R. INOUE
Physiological Features of Visceral Smooth Muscle Cells, With Special Reference to Receptors and Ion Channels
Physiol Rev, July 1, 1998; 78(3): 811 - 920.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the European Respiratory Society.